A carregar...
Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
Hydroxyurea is the gold standard treatment for prevention of vaso-occlusive crises in patients with sickle-cell anaemia. It has a narrow therapeutic index and dangerous side effects including cytopenias. There is high variation in dose–response across the population. Therefore, a robust outpatient m...
Na minha lista:
| Publicado no: | BMJ Open Qual |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5878251/ https://ncbi.nlm.nih.gov/pubmed/29610772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjoq-2017-000218 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|